Sun Pharma has launched Fexuclue (Fexuprazan), a new drug in India for Erosive Esophagitis treatment, achieving over 95% healing in patients within 8 weeks. The drug is a potassium-competitive acid blocker, with a long half-life of 9 hours, and was confirmed effective in clinical trials.